CHOICE faculty member Doug Barthold was awarded the Alzheimer’s Disease Research Center Pilot Award, for a proposal titled “Alzheimer’s disease related neuropathology among patients with medication treated type 2 diabetes in a community-based autopsy cohort.”
The award is for one year. His study will look at the relationship between use of type II diabetes medications and Alzheimer’s disease related neuropathology.
Alzheimer’s disease-related neuropathology is one of the signs of Alzheimer’s disease that are observed in an autopsied brain. Many other studies have found links between diabetes medications and the clinical presentation of Alzheimer’s disease, but researchers have yet to examine the neuropathology of diabetes medication users.
This is important, because there are inconsistencies between what clinicians observe and what is seen in the brain after an autopsy.